0001683168-23-007106.txt : 20231012
0001683168-23-007106.hdr.sgml : 20231012
20231012180006
ACCESSION NUMBER: 0001683168-23-007106
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230921
FILED AS OF DATE: 20231012
DATE AS OF CHANGE: 20231012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andraczke Andrzej
CENTRAL INDEX KEY: 0001792732
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 231323505
MAIL ADDRESS:
STREET 1: C/O CNS PHARMACEUTICALS, INC.
STREET 2: 2100 WEST LOOP SOUTH STE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4/A
1
ownership.xml
X0508
4/A
2023-09-21
2023-09-25
0
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0001792732
Andraczke Andrzej
C/O CNS PHARMACEUTICALS, INC.
100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
1
0
0
0
0
Option to purchase common stock
1.09
2023-09-21
4
A
0
39475
A
2033-09-22
Common Stock
39475
45428
D
The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
The stock options were issued in connection with the reporting person's Board of Director services to the Company.
This amendment is being filed solely to correct the number of shares of common stock underlying the reported option, and total number of derivative securities owned following the reported transaction.
/s/ Christopher Downs, Attorney-in-fact
2023-10-12